127 related articles for article (PubMed ID: 17146174)
1. Expression patterns of the slit subfamily mRNA in canine malignant mammary tumors.
Tanno T; Tanaka Y; Sugiura T; Akiyoshi H; Takenaka S; Kuwamura M; Yamate J; Ohashi F; Kubo K; Tsuyama S
J Vet Med Sci; 2006 Nov; 68(11):1173-7. PubMed ID: 17146174
[TBL] [Abstract][Full Text] [Related]
2. Expression patterns of the erbB subfamily mRNA in canine benign and malignant mammary tumors.
Matsuyama S; Nakamura M; Yonezawa K; Shimada T; Ohashi F; Takamori Y; Kubo K
J Vet Med Sci; 2001 Sep; 63(9):949-54. PubMed ID: 11642281
[TBL] [Abstract][Full Text] [Related]
3. Molecular cloning of canine nm23 cDNAs and their expression in normal and tumor tissues.
Takahashi M; Une R; Fukushima K; Fujiki M; Misumi K; Miyoshi N; Endo Y; Ohishi A; Akuzawa M
J Vet Med Sci; 2005 Aug; 67(8):837-41. PubMed ID: 16141675
[TBL] [Abstract][Full Text] [Related]
4. Expression patterns of connexin 26 and connexin 43 mRNA in canine benign and malignant mammary tumours.
Gotoh H; Harada K; Suzuki K; Hashimoto S; Yamamura H; Sato T; Fukumoto K; Hagiwara H; Ishida T; Yamada K; Asano R; Yano T
Vet J; 2006 Jul; 172(1):178-80. PubMed ID: 16772144
[TBL] [Abstract][Full Text] [Related]
5. The combined expression pattern of BMP2, LTBP4, and DERL1 discriminates malignant from benign canine mammary tumors.
Klopfleisch R; Klose P; Gruber AD
Vet Pathol; 2010 May; 47(3):446-54. PubMed ID: 20375427
[TBL] [Abstract][Full Text] [Related]
6. Cloning and expression analysis of prohibitin mRNA in canine mammary tumors.
Matsuyama S; Nakano Y; Nakamura M; Yamamoto R; Shimada T; Ohashi F; Kubo K
J Vet Med Sci; 2015 Jan; 77(1):101-4. PubMed ID: 25312047
[TBL] [Abstract][Full Text] [Related]
7. Reduced canine BRCA2 expression levels in mammary gland tumors.
Yoshikawa Y; Morimatsu M; Ochiai K; Ishiguro-Oonuma T; Wada S; Orino K; Watanabe K
BMC Vet Res; 2015 Jul; 11():159. PubMed ID: 26202431
[TBL] [Abstract][Full Text] [Related]
8. Frequent expression of the c-kit proto-oncogene in canine malignant mammary tumor.
Kubo K; Matsuyama S; Katayama K; Tsutsumi C; Yonezawa K; Shimada T; Kotani T; Sakuma S; Ohashi F; Takamori Y
J Vet Med Sci; 1998 Dec; 60(12):1335-40. PubMed ID: 9879535
[TBL] [Abstract][Full Text] [Related]
9. Increased expression of C5a receptor (CD88) mRNA in canine mammary tumors.
Hezmee MN; Kyaw-Tanner M; Lee JY; Shiels IA; Rolfe B; Woodruff T; Mills PC
Vet Immunol Immunopathol; 2011 Jan; 139(1):50-6. PubMed ID: 20846729
[TBL] [Abstract][Full Text] [Related]
10. Telomerase reverse transcriptase (TERT) expression in canine mammary tissues: a specific marker for malignancy?
Zavlaris M; Angelopoulou K; Vlemmas I; Papaioannou N
Anticancer Res; 2009 Jan; 29(1):319-25. PubMed ID: 19331168
[TBL] [Abstract][Full Text] [Related]
11. Molecular cloning and tumour suppressor function analysis of canine REIC/Dkk-3 in mammary gland tumours.
Ochiai K; Watanabe M; Azakami D; Michishita M; Yoshikawa Y; Udagawa C; Metheenukul P; Chahomchuen T; Aoki H; Kumon H; Morimatsu M; Omi T
Vet J; 2013 Sep; 197(3):769-75. PubMed ID: 23732075
[TBL] [Abstract][Full Text] [Related]
12. Growth hormone mRNA in mammary gland tumors of dogs and cats.
Mol JA; van Garderen E; Selman PJ; Wolfswinkel J; Rijinberk A; Rutteman GR
J Clin Invest; 1995 May; 95(5):2028-34. PubMed ID: 7738169
[TBL] [Abstract][Full Text] [Related]
13. Expression of the PTEN tumor suppressor gene in malignant mammary gland tumors of dogs.
Kanae Y; Endoh D; Yokota H; Taniyama H; Hayashi M
Am J Vet Res; 2006 Jan; 67(1):127-33. PubMed ID: 16426222
[TBL] [Abstract][Full Text] [Related]
14. Expression of versican in relation to chondrogenesis-related extracellular matrix components in canine mammary tumors.
Erdélyi I; van Asten AJ; van Dijk JE; Nederbragt H
Histochem Cell Biol; 2005 Aug; 124(2):139-49. PubMed ID: 16088379
[TBL] [Abstract][Full Text] [Related]
15. Cloning and cellular localization of the canine progesterone receptor: co-localization with growth hormone in the mammary gland.
Lantinga-van Leeuwen IS; van Garderen E; Rutteman GR; Mol JA
J Steroid Biochem Mol Biol; 2000 Dec; 75(4-5):219-28. PubMed ID: 11282275
[TBL] [Abstract][Full Text] [Related]
16. Derlin-1 and stanniocalcin-1 are differentially regulated in metastasizing canine mammary adenocarcinomas.
Klopfleisch R; Gruber AD
J Comp Pathol; 2009; 141(2-3):113-20. PubMed ID: 19515379
[TBL] [Abstract][Full Text] [Related]
17. Quantification of VEGF-C expression in canine mammary tumours.
Qiu C; Lin DD; Wang HH; Qiao CH; Wang J; Zhang T
Aust Vet J; 2008 Jul; 86(7):279-82. PubMed ID: 18616481
[TBL] [Abstract][Full Text] [Related]
18. Calreticulin expression in neoplastic versus normal dog mammary glands: a cDNA subtraction-based study.
Okawa T; Kurio Y; Morimoto M; Hayashi T; Nakagawa T; Sasaki N; Okuda M; Mizuno T
Res Vet Sci; 2012 Feb; 92(1):80-91. PubMed ID: 21126744
[TBL] [Abstract][Full Text] [Related]
19. Prognostic value of vascular endothelial growth factor and hypoxia-inducible factor 1α in canine malignant mammary tumors.
Moschetta MG; Maschio LB; Jardim-Perassi BV; Gelaleti GB; Lopes JR; Leonel C; Gonçalves Ndo N; Ferreira LC; Martins GR; Borin TF; Zuccari DA
Oncol Rep; 2015 May; 33(5):2345-53. PubMed ID: 25779537
[TBL] [Abstract][Full Text] [Related]
20. Over-expression of mammaglobin-B in canine mammary tumors.
Pandey M; Sunil Kumar BV; Gupta K; Sethi RS; Kumar A; Verma R
BMC Vet Res; 2018 Jun; 14(1):184. PubMed ID: 29903015
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
